Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46552, first published .
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium

Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium

Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium

Michael A Diefenbach   1 , PhD ;   Allison Marziliano   1 , PhD ;   Erin K Tagai   2 , MPH, PhD ;   Halie Pfister   1 , MPH ;   Emmanuel Lapitan   2 , BA ;   Simon J Hall   1, 3 , MD ;   Manish Vira   1, 3 , MD ;   Said Ibrahim   1 , MD ;   Kelli Aibel   1 , MPH, MD ;   Alexander Kutikov   4 , MD ;   Eric M Horwitz   5, 6 , MD ;   Curtis Miyamoto   5, 6 , MD ;   Adam C Reese   4, 6 , MD ;   Suzanne M Miller   2 , PhD

1 Institute of Health System Science, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States

2 Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States

3 Smith Institute for Urology, Northwell Cancer Institute, Northwell Health, Manhasset, NY, United States

4 Department of Urology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States

5 Department of Radiation Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States

6 Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States

Corresponding Author:

  • Michael A Diefenbach, PhD
  • Institute of Health System Science
  • The Feinstein Institutes for Medical Research
  • Northwell Health
  • 600 Community Drive
  • Suite 403
  • Manhasset, NY, 11030
  • United States
  • Phone: 1 516-600-1400
  • Email: mdiefenbach@northwell.edu